Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular disease

Cardiovascular Drugs and Therapy

Volumn 10, Issue 4, 1996, Pages 455-461

  Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Acute myocardial infarction; Angina; Beta blocker; Black patients; Calcium antagonists; Hypertension; Post infarct therapy; Vasospasm

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; DIURETIC AGENT; GLYCERYL TRINITRATE; METOPROLOL; NIFEDIPINE; VERAPAMIL;

ACUTE HEART INFARCTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRINZMETAL ANGINA PECTORIS; PRIORITY JOURNAL; Q WAVE; RAYNAUD PHENOMENON; SIDE EFFECT; SYSTOLIC HYPERTENSION; VASOSPASM;

AFRICAN AMERICANS; AGED; ANGINA PECTORIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION;

EID: 0029860534     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051110     Document Type: Article

References (37)

1. Furberg CD, Psaty BM, Meyer JV. Nifedipine, Doserelated increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
2. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
3. Pahor M, Guralnik JM, Corti M, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43: 1191-1197.
4. Opie LH, Messerli FH. Nifedipine and mortality. Grave defects in the dossier. Circulation 1995;92:1068-1073.
5. Tsevat J, Duke D, Goldman L, et al. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol 1995;26:914-919.
6. Pepine CJ, Cohn PF, Prakash C, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-768.
7. Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs. verapamil in patients with stable angina pectoris. The Angina Prognosis Study In Stockholm (APSIS). Eur Heart J 1996;17:76-81.
8. Dargie HJJ, for the TIBET Study Group. Medical treatment of angina can favourably affect outcome. Eur Heart J 1993;14(Abstract Suppl):304.
9. Opie LH. Calcium channel antagonists in the management of anginal syndromes: Changing concepts in relation to the role of coronary vasospasm. Prog Cardiovase Dis 1996;38: 291-314.
10. Göbel EJAM, Hautvast RWM, van Gilst WH, et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995;346:1653-1657.
11. Ferguson JJ, Momomura S. Highlights from the 58th Annual Scientific Meeting of the Japanese Circulation Society. Circulation 1994;90:2194-2196.
12. Theusen L, Jorgenson JR, Kvistgaard HJ. Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: A double-blind randomized trial. Br Med J 1983;286:1107-1108.
13. Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Br J Clin Pharmacol 1986;21:197S-204S.
14. Goldbourt U, Behar S, Reicher-Reiss H, et al. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993;153: 345-353.
15. Sirnes PA, Overskeid K, Pedersen TR, Bathen J, et al. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial. Circulation 1984;70:638-644.
16. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992;19:1622-1623.
17. Fischer Hansen J, The Danish Study Group on verapamil in myocardial infarction. Treatment with verapamil during and after an acute myocardial infarction: A review based on the Danish verapamil infarction trials I and II. J Cardiovasc Pharmacol 1991;18(Suppl 6):S20-S25.
18. Fischer Hansen J. Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction. Cardiovasc Drugs Ther 1993;7:381-382.
19. Messerli F, WE Boden, Fischer-Hansen J, Schechtman KB. Heart rate lowering calcium antagonists (HRL-CA) in hypertensive post MI patients. J Am Coll Cardiol 1996;27: 178A.
20. Boden WE, Fisher-Hansen J, Lau J, Roberts R. Beneficial effect of heart rate-lowering calcium channel blockers (diltiazem, verapamil) on reducing long-term (12-18 month) cardiac death and nonfatal reinfarction in patients recovering from acute non-Q-wave myocardial infarction (abstr). Circulation 1995;92(Suppl):1-81.
21. Lichstein E, Hager D, Gregory JJ, Fleiss JL, Rolnitzky LM, Bigger JT. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. J Am Coll Cardiol 1990;16:1327-1332.
22. Poole-Wilson PA. DEFIANT II: The effect of nisoldipine vs. placebo on ventricular function and exercise capacity. Presented at the 17th Congress of European Society of Cardiology, Amsterdam, The Netherlands, 1995.
23. Packer M. The PRAISE trial (Prospective Randomized Amlodipine Survival Evaluation): Background and main results. Presented at the American College of Cardiology Annual Meeting, 1995.
24. Cohn JN. V-HEFT-III: Efficacy and outcome with felodipine in heart failure. Presented at the 17th-Congress of the European Society of Cardiology, Amsterdam, The Netherlands, 1995.
25. Gong L, Zwang W, Zhu Y. STONE (Shanghai Trial Of Nifedipine in the Elderly) Study. Abstract presented to the Seventh European Meeting on Hypertension, 1995.
26. MRC Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985;291:97-104.
27. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. Br Med J 1992;304:405-412.
28. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-1857.
29. Hoes AW, Grobbee DE, Lubsen J, Man in 't Veld AJ, van der Does E, Hofman A. Diuretics, β-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995;123:481-487.
30. Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:24: 3255-3264.
31. Ekbom R, Dahlöf B, Hansson L, et al. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: A report from the STOP-Hypertension study. J Hypertens 1992;10:1525-1530.
32. Warram JH, Laffel LMB, Valsania P, Christlieb AR, Krolewski AS. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991;151:1350-1356.
33. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328: 914-921.
34. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993;270: 713-724.
35. Kailasam MT, Parmer RJ, Cervenka JH, et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995;26:143-149.
36. Arstall MA, Beltrame JF, Mohan P, Wuttke RD, Esterman AJ, Horowitz JD. Incidence and adverse effects during treatment with verapamil for suspected acute myocardial infarction. Am J Cardiol 1992;70:1611-1612.
37. Pahor M, Guralnik JM, Furberg C, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-1065.